ArticleJournal of nanobiotechnology2025

Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer.

Yuwei Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.